Indeed, in our hands, SARS-CoV-2 infection alone led to an increased release of inflammasome-dependent and independent proinflammatory cytokines such as IL-18 and IL-33, respectively, as well as to the decrease of anti-viral CCL4 in controls and in asthma. The gene discussed is CCL4; the disease is asthma.